COLUMBUS, Ohio--()--Today throughout Ohio, at least 1,280 bioscience-related organizations are either manufacturing products, providing essential services, or researching the next breakthrough.
Ranging from the large and well known—like Battelle, Steris, Cardinal Health, and Ethicon Endo-Surgery—to the young and growing—like Cleveland HeartLab, AssureRx, Riverain Medical, and MID—Ohio bioscience firms employ 60,600 workers, according to an industry growth report released today by BioOhio. Since 2000, Ohio bioscience employment increased 16.5% (8,574 jobs), while overall employment in Ohio declined.
Ohio’s bioscience industry generated $4.58 billion of payroll in 2011, a 31% ($1.08 billion) increase since 2000. Bioscience sector jobs in Ohio paid an average wage of $75,523, encompassing a wide variety of occupations, not just scientists and executives. In comparison, the average wage for all industries in Ohio in 2011 was $42,588.
In 2011, Ohio’s bioscience sector included 1,281 unique firms operating 1,743 locations, an increase of 441 (33.9%) since 2000. Almost 70% of Ohio’s bioscience businesses fit into two subsectors: medical and testing laboratories (618 locations) and medical device and equipment manufacturers (585).
The bioscience industry’s economic impact is felt throughout the state, with bioscience-related companies found in 73 of 88 Ohio counties.
Anchored by Cleveland and Akron, northeast Ohio led the state in number of bioscience locations with 42% of the total in 2011. The central and southwest regions followed with 319 (18%) and 288 (17%), respectively. Since 2000 all six Ohio regions have added bioscience locations.
Between 2005 and July 2012, 308 bioscience companies have either expanded operations or announced new facilities in the state. Global brands like Philips Healthcare, NAMSA, PharmaForce, and Medpace are examples of companies that have completed expansions in the past two years.
From 2007 to 2011, at least 380 new bioscience-related firms began operations in Ohio—an average of 76 each year. These include both start-up companies, like Great Lakes Neurotech and N8 Medical, and those that established their first facilities in Ohio, such as Hamlet Protein and TeraView.
Ohio-based institutions and companies received $710.9 million from the National Institutes of Health (NIH) in 2011, well ahead of the U.S. average of $439.9 million. Five institutions—Case Western Reserve University, Ohio State University, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, and The Cleveland Clinic—were once again among the nation’s top 100 NIH funding recipients.
In 2011 Ohioans received 3,177 total issued patents, 685 of which were bioscience-related. Ohio ranks 8th nationally in bio-related patents, keeping well ahead of the U.S. average of 370.
Of the 450 Ohio post-secondary educational institutions, 105 awarded bioscience-related degrees or certificates. The number of Ohio bioscience graduates was 8,820 in 2011, up 37% since 2006. Degrees awarded in 2011 included 1,423 certificates or associates degrees, 5,413 bachelor’s degrees, and 1,984 post-BA, master’s or doctoral degrees.
Ohio companies attracted nearly $2.4 billion in overall funding from multiple sources in 2011, including venture capital, acquisitions, angel investors, federal grants, and state initiatives like the Ohio Third Frontier.
The Ohio Bioscience Growth Report contains additional detail. For the complete report and appendix, visit www.bioohio.com/pdfs/growthreport12.aspx.
BioOhio is a non-profit organization supported by the Thomas Edison Program of the Ohio Department of Development. Its mission is to accelerate bioscience discovery, innovation and commercialization of global value, driving economic growth, and improving quality of life in Ohio. BioOhio is headquartered in Columbus, with regional business development affiliates in Cleveland, Columbus, Cincinnati and Athens.